Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Myeloproliferative Neoplasm
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Participants will be randomized to either Mediterranean or Dietary Approaches to Stop Hypertension (DASH) dietMasking: Single (Participant)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04744974
Collaborators
Not Provided
Investigators
Principal Investigator: Angela G. Fleischman, MD PhD University of California, Irvine